BOISE, Idaho — Idaho is getting roughly $483,000 from EpiPen maker Mylan as part of a multi-state settlement.

Attorney General Lawrence Wasden on Friday announced the state’s share of the $465 million federal agreement completed in August that settled allegations it overbilled Medicaid programs for its emergency allergy injectors for nearly a decade.

It’s the second settlement with the U.S. Department of Justice that Mylan has made since 2009 for allegedly overcharging the government. The latest case involves Mylan paying Medicaid too-low rebates for the devices by classifying its brand-name product as a generic, which requires lower rebates.